Literature DB >> 3762523

Immunochemical identification of cytochrome P-450 isozyme 3a (P-450ALC) in rabbit nasal and kidney microsomes and evidence for differential induction by alcohol.

X X Ding, D R Koop, B L Crump, M J Coon.   

Abstract

Polyclonal and monoclonal antibodies to rabbit liver microsomal alcohol-inducible cytochrome P-450 isozyme 3a (P-450ALC) were used to examine the tissue distribution of the cytochrome. Isozyme 3a or an immunochemically indistinguishable variant of this protein was detected on immunoblots of kidney and nasal mucosa microsomes, but not of microsomes prepared from brain, lung, adrenal, heart, intestine, ovary, spleen, testis, or uterus from untreated or ethanol-treated rabbits. The presence of isozyme 3a was also indicated by inhibition by anti-3a IgG of microsomal aniline hydroxylation and butanol oxidation. The identity of isozyme 3a was further substantiated by peptide-mapping analysis of the immunoaffinity-purified proteins. The amount of isozyme 3a was increased in kidney, but not in nasal microsomes, by chronic ethanol treatment. The induction of isozyme 3a in the kidney was reflected in a more than 2-fold increase in the total rates and a 7-fold increase in the isozyme 3a-dependent rates of aniline and butanol metabolism. Based on immunoblot quantitation, the specific content of isozyme 3a is about 10 pmol/mg of protein in kidney and 80 pmol/mg of protein in nasal microsomes of untreated rabbits. After ethanol treatment of the animals, the content increases to 50 pmol/mg of protein in kidney but is unchanged in nasal microsomes. The presence of isozyme 3a may play a significant role in the toxicity of foreign compounds.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3762523

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Effects of acetone administration on cytochrome P-450-dependent monooxygenases in hamster liver, kidney, and lung.

Authors:  T H Ueng; J N Tsai; J M Ju; Y F Ueng; M Iwasaki; F P Guengerich
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

Review 2.  Drug metabolism in the nasal mucosa.

Authors:  M A Sarkar
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

3.  Stimulatory effects of benzene on rabbit liver and kidney microsomal cytochrome P-450 dependent drug metabolizing enzymes.

Authors:  E Arinç; O Adali; M Işcan; T Güray
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

4.  The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450.

Authors:  G I Murray; T S Barnes; H F Sewell; S W Ewen; W T Melvin; M D Burke
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

5.  cDNA and derived amino acid sequence of ethanol-inducible rabbit liver cytochrome P-450 isozyme 3a (P-450ALC).

Authors:  S C Khani; P G Zaphiropoulos; V S Fujita; T D Porter; D R Koop; M J Coon
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Effects of herbal products and their constituents on human cytochrome P450(2E1) activity.

Authors:  Gregory M Raner; Sean Cornelious; Kamalika Moulick; Yingqing Wang; Ashley Mortenson; Nadja B Cech
Journal:  Food Chem Toxicol       Date:  2007-06-15       Impact factor: 6.023

7.  Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.

Authors:  A K Daly; S Cholerton; M Armstrong; J R Idle
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

Review 8.  Biotransformation enzymes in the rodent nasal mucosa: the value of a histochemical approach.

Authors:  M S Bogdanffy
Journal:  Environ Health Perspect       Date:  1990-04       Impact factor: 9.031

9.  Cytochrome P-450 isozyme pattern is related to individual susceptibility to diethylnitrosamine-induced liver cancer in rats.

Authors:  A Aitio; M L Aitio; A M Camus; E Cardis; H Bartsch
Journal:  Jpn J Cancer Res       Date:  1991-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.